重复口服葡萄糖耐量试验与持续葡萄糖监测预测3期1型糖尿病发生的比较:一项纵向分析
研究纳入34例多种自身抗体阳性的1型糖尿病一级亲属,随访中位3.5年,比较重复CGM、HbA1c与OGTT指标预测进展至3期1型糖尿病的效能。横断面分析中最佳OGTT与CGM指标预测快速进展的ROC AUC为0.86-0.92,预测总体进展的一致性为0.73-0.78;纵向模型中OGTT衍生的AUC葡萄糖(AICc=71)优于最佳CGM指标(AICc=75)和HbA1c(AICc=80),但重复CGM与HbA1c联合(AICc=68)接近OGTT多变量模型(AICc=59)。作者认为重复CGM和HbA1c在纵向模型中预测效能几乎与OGTT相当,可能更便于长期临床监测。
要点
- 横断面分析中最佳OGTT与CGM指标预测快速进展的ROC AUC为0.86-0.92。
- 纵向模型中OGTT衍生的AUC葡萄糖(AICc=71)优于最佳CGM指标(AICc=75)和HbA1c(AICc=80)。
- 重复CGM联合HbA1c(AICc=68)接近但未优于OGTT多变量模型(AICc=59)。
核心结论
- 在纵向模型中,重复CGM和HbA1c预测3期1型糖尿病的效能几乎与OGTT相当,可能更便于长期临床监测。
研究设计与样本
- 多中心研究,纳入34例多种自身抗体阳性且BMI标准差评分(SDS)<2的一级亲属,每半年进行5天CGM记录、HbA1c和OGTT,中位随访3.5年(IQR 2.0-7.5)。
- 采用ROC曲线下面积(AUC)、Kaplan-Meier法、基线Cox比例风险模型(一致性)及含时变协变量的扩展Cox模型(n=197次OGTT及同步CGM记录),并校正个体内相关性(校正AICc)。
主要发现
- 中位40个月(IQR 20-91)后,34例一级亲属中17例进展至3期1型糖尿病,基线中位年龄16.6岁。
- CGM指标在接近发病时升高,与OGTT变化平行,两者均有较大的个体内和个体间变异。
- 横断面分析中,最佳OGTT与CGM指标预测快速进展的ROC AUC为0.86-0.92,预测总体进展的一致性为0.73-0.78。
- 纵向模型中,OGTT衍生的AUC葡萄糖(AICc=71)优于最佳CGM指标(AICc=75)和HbA1c(AICc=80),所有P<0.001。
- HbA1c补充重复CGM指标(AICc=68),但基于OGTT的多变量模型仍更优(AICc=59)。
临床怎么用
- 作者认为,在纵向模型中重复CGM和HbA1c预测3期1型糖尿病的效能几乎与OGTT相当,可能更便于长期临床监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evidence for using continuous glucose monitoring (CGM) as an alternative to oral glucose tolerance tests (OGTTs) in presymptomatic type 1 diabetes is primarily cross-sectional. We used longitudinal data to compare the diagnostic performance of repeated CGM, HbA1c, and OGTT metrics to predict progression to stage 3 type 1 diabetes. RESEARCH DESIGN AND METHODS: Thirty-four multiple autoantibody-positive first-degree relatives (FDRs) (BMI SD score [SDS] <2) were followed in a multicenter study with semiannual 5-day CGM recordings, HbA1c, and OGTT for a median of 3.5 (interquartile range [IQR] 2.0-7.5) years. Longitudinal patterns were compared based on progression status. Prediction of rapid (<3 years) and overall progression to stage 3 was assessed using receiver operating characteristic (ROC) areas under the curve (AUCs), Kaplan-Meier method, baseline Cox proportional hazards models (concordance), and extended Cox proportional hazards models with time-varying covariates in multiple record data (n = 197 OGTTs and concomitant CGM recordings), adjusted for intraindividual correlations (corrected Akaike information criterion [AICc]). RESULTS: After a median of 40 (IQR 20-91) months, 17 of 34 FDRs (baseline median age 16.6 years) developed stage 3 type 1 diabetes. CGM metrics increased close to onset, paralleling changes in OGTT, both with substantial intra- and interindividual variability. Cross-sectionally, the best OGTT and CGM metrics similarly predicted rapid (ROC AUC = 0.86-0.92) and overall progression (concordance = 0.73-0.78). In longitudinal models, OGTT-derived AUC glucose (AICc = 71) outperformed the best CGM metric (AICc = 75) and HbA1c (AICc = 80) (all P < 0.001). HbA1c complemented repeated CGM metrics (AICc = 68), though OGTT-based multivariable models remained superior (AICc = 59). CONCLUSIONS: In longitudinal models, repeated CGM and HbA1c were nearly as effective as OGTT in predicting stage 3 type 1 diabetes and may be more convenient for long-term clinical monitoring.
引用
- Desouter AK, Keymeulen B, Van de Velde U, et al. Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis. Diabetes Care. 2025. PMID: 39903487. doi:10.2337/dc24-2376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。